T2 Biosystems, Inc. (TTOO)
NASDAQ: TTOO · IEX Real-Time Price · USD
2.840
+0.100 (3.65%)
At close: Apr 26, 2024, 4:00 PM
2.850
+0.010 (0.35%)
After-hours: Apr 26, 2024, 7:58 PM EDT

T2 Biosystems Revenue

In the year 2023, T2 Biosystems had annual revenue of $7.19M, a decrease of -67.75%. Revenue in the quarter ending December 31, 2023 was $1.68M, a -69.38% decrease year-over-year.

Revenue (ttm)
$7.19M
Revenue Growth
-67.75%
P/S Ratio
2.18
Revenue / Employee
$63,655
Employees
113
Market Cap
15.66M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.19M-15.11M-67.75%
Dec 31, 202222.31M-5.75M-20.50%
Dec 31, 202128.06M9.93M54.76%
Dec 31, 202018.13M9.80M117.52%
Dec 31, 20198.34M-2.17M-20.62%
Dec 31, 201810.50M5.83M125.03%
Dec 31, 20174.67M586.00K14.36%
Dec 31, 20164.08M1.27M45.04%
Dec 31, 20152.81M2.69M2,263.87%
Dec 31, 2014119.00K-147.00K-55.26%
Dec 31, 2013266.00K247.00K1,300.00%
Dec 31, 201219.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ETAO International Co. 58.06M
Psychemedics 22.10M
Immuron 2.43M
Avalo Therapeutics 1.92M
Mainz Biomed B.V. 895.48K
iBio, Inc. 50.00K
BioSig Technologies 18.00K
Revenue Rankings